Medi-Ject gains German distribution:
This article was originally published in Clinica
Medi-Ject has signed an exclusive distribution agreement with Rolf Deerberg Geratbau, based in Buckeberg, Germany, to distribute the Medi-Jector Choice needle-free insulin injector in Germany. Minneapolis, Minnesota-based Medi-Ject derives more than 50% of its sales from the European market and has already entered the insulin delivery market in Scandinavia and Spain. The company predicts that it will rapidly build distribution in Germany and the remaining EU territories.
You may also be interested in...
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
US FDA Will Need About A Week To Complete COVID Vaccine Assessment Following Advisory Cmte., CBER’s Marks Says
Timeline is the most pessimistic public projection to date, but still incredibly fast. Clinical trial patients on placebo could be contacted and offered the vaccine after an EUA is granted.